NeuroOne Medical Technologies Corporation/$NMTC
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
Ticker
$NMTC
Sector
Primary listing
Employees
18
Headquarters
Website
NMTC Metrics
BasicAdvanced
$46M
-
-$0.09
0.69
-
Price and volume
Market cap
$46M
Beta
0.69
52-week high
$1.16
52-week low
$0.40
Average daily volume
352K
Financial strength
Current ratio
4.44
Quick ratio
3.402
Long term debt to equity
2.024
Total debt to equity
3.772
Interest coverage (TTM)
-21.13%
Profitability
EBITDA (TTM)
-3.965
Gross margin (TTM)
26.10%
Net profit margin (TTM)
-29.80%
Operating margin (TTM)
-34.94%
Revenue per employee (TTM)
$670,000
Management effectiveness
Return on assets (TTM)
-32.70%
Return on equity (TTM)
-91.34%
Valuation
Price to revenue (TTM)
2.996
Price to book
6.38
Price to tangible book (TTM)
6.42
Price to free cash flow (TTM)
-12.419
Free cash flow yield (TTM)
-8.05%
Free cash flow per share (TTM)
-0.073
Growth
Revenue change (TTM)
250.35%
Earnings per share change (TTM)
-80.49%
3-year revenue growth (CAGR)
78.70%
3-year earnings per share growth (CAGR)
-47.63%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for NeuroOne Medical Technologies Corporation stock?
NeuroOne Medical Technologies Corporation (NMTC) has a market cap of $46M as of January 21, 2026.
What is the P/E ratio for NeuroOne Medical Technologies Corporation stock?
The price to earnings (P/E) ratio for NeuroOne Medical Technologies Corporation (NMTC) stock is 0 as of January 21, 2026.
Does NeuroOne Medical Technologies Corporation stock pay dividends?
No, NeuroOne Medical Technologies Corporation (NMTC) stock does not pay dividends to its shareholders as of January 21, 2026.
When is the next NeuroOne Medical Technologies Corporation dividend payment date?
NeuroOne Medical Technologies Corporation (NMTC) stock does not pay dividends to its shareholders.
What is the beta indicator for NeuroOne Medical Technologies Corporation?
NeuroOne Medical Technologies Corporation (NMTC) has a beta rating of 0.69. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.